Evidence map›Paper›PMID 29615189›Full record

ReviewBiological psychiatry2018

Translational Assessments of Reward and Anhedonia: A Tribute to Athina Markou.

Andre Der-Avakian, Diego A Pizzagalli

Abstract readReview
In one paragraph

Review in Biological psychiatry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Developmental Trajectories of Anhedonia in Preclinical Models.Current topics in behavioral neurosciences · 2022
    Article
  10. Clinical and Preclinical Assessments of Anhedonia in Psychiatric Disorders.Current topics in behavioral neurosciences · 2022
    Article
  11. Probabilistic Reinforcement Learning and Anhedonia.Current topics in behavioral neurosciences · 2022
    Article
  12. Prefrontal cortex and depression.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. The Importance of Common Currency Tasks in Translational Psychiatry.Current behavioral neuroscience reports · 2021
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Andre Der-AvakianDepartment of Psychiatry, University of California San Diego, La Jolla, California. Electronic address: aderavakian@ucsd.edu.
Diego A PizzagalliDepartment of Psychiatry, Harvard Medical School, Belmont, Massachusetts.

Funding

Neuroimaging Studies of Reward Processing in DepressionR37MH068376 · NIMH · UNIVERSITY OF CALIFORNIA-IRVINE · PI Diego A Pizzagalli · 2016 to 2026
$7.4M
Early Life Stress and Depression: Molecular and Functional Imaging ApproachesR01MH095809 · NIMH · MCLEAN HOSPITAL · PI DU, FEI, PIZZAGALLI, DIEGO A · 2012 to 2024
$6.4M
Novel Cross-Species Neurophysiological Assays of Reward and Cognitive DomainsUH2MH109334 · NIMH · MCLEAN HOSPITAL · PI PIZZAGALLI, DIEGO A · 2016 to 2017
$1.5M
Developing rodent models of PTSD/AUD: leveraging clinic-based strategiesR01AA026560 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DER-AVAKIAN, ANDRE, RISBROUGH, VICTORIA B · 2017 to 2021
$1.2M
NIAAA NIH HHS R01 AA026560NIMH NIH HHS R37 MH068376NIMH NIH HHS UH2 MH109334
6 · The paper itself

Abstract

Loss of pleasure (clinically referred to as anhedonia), impairments in other reward-related processes such as reward learning, motivation, and reward valuation, and blunted affect characterize several mood and other psychiatric disorders. Despite the availability of many therapeutic options for these disorders, reward-related impairments remain challenging to treat and often persist despite alleviation of other symptoms. Lack of animal models of reward-related impairments and affect that have high construct and predictive validity is a key obstacle to developing novel treatments. This review highlights 1) guidelines to consider when developing translatable animal models; and 2) recent efforts to develop new reward-related assessments in humans and nonhuman animals that have been translated or back-translated from one species to another. The procedures described in this review are used to assess aspects of reward learning, motivated behavior, reward valuation, and affect. In several cases, researchers have attempted to implement task parameters that are as identical as possible to the parallel parameters used in existing cross-species tasks, with the goal of improving the translation of preclinical drug discovery findings to the clinic. In this regard, Dr. Athina Markou, who worked tirelessly throughout her career to understand and treat reward-related impairments across several psychiatric disorders, had great influence on conceptualizing the development and use of translational animal models of reward-related processes.

Indexed as

AnhedoniaMotivationRewardAnimalsGuidelines as TopicHumansModels, AnimalTranslational Research, BiomedicalCross-speciesMotivationPleasurePositive valence systemsRDoCReward

Identifiers

PMID29615189
PMCPMC5953796

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.